Molecular Partners (MOLN) Short Interest Ratio & Short Volume

Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 39,200 shares of MOLN short. 0.11% of Molecular Partners' shares are currently sold short. Learn More on Molecular Partners' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 10.0. Learn More on Molecular Partners's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Molecular Partners' floating shares are currently sold short.

Molecular Partners saw a decrease in short interest in March. As of March 31st, there was short interest totaling 39,200 shares, a decrease of 3.0% from the previous total of 40,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Molecular Partners currently has issued a total of 40,375,000 shares. Some of Molecular Partners' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Molecular Partners currently has a public float of 36,770,000 shares.

0.11% of Molecular Partners' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Molecular Partners: ArriVent BioPharma, Inc. (20.95%), Trevi Therapeutics, Inc. (9.46%), Pharming Group (0.00%), Rocket Pharmaceuticals, Inc. (19.09%), AnaptysBio, Inc. (53.19%), Cogent Biosciences, Inc. (12.51%), LENZ Therapeutics, Inc. (11.10%), Opthea Limited (0.36%), Dianthus Therapeutics, Inc. (23.78%), Immunome, Inc. (14.76%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is March, 31 2025.